EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

CX3CL1-CX3CR1 signaling orchestrates malignant progression of prostate cancer through luminal progenitor-macrophage crosstalk

Yu Jiang, Yuchen Guo, Lizhuang Han, Shiwei Wang, Fang Wang, Yongliang Zhao, Jiajia Wang, Junyan Han, Miaomiao Liu, Zhihua Liu, Qin Zhang

Cellular Oncology · 2026

DOI: 10.1007/s13402-026-01179-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Oncology, 2026. Verfasst von Yu Jiang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Innovation Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, 100038, China. Hauptthemen laut MEDLINE: CX3C Chemokine Receptor 1, Chemokine CX3CL1, Signal Transduction, Disease Progression. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: the National Natural Science Foundation of China, Joint Research Center for Genomic Resources, State Key Laboratory of Membrane Biology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CX3C Chemokine Receptor 1Chemokine CX3CL1Signal TransductionDisease ProgressionProstatic NeoplasmsNeoplastic Stem CellsMacrophagesMaleAnimalsHumansTumor MicroenvironmentMiceTumor-Associated MacrophagesCell Line, Tumor

Stichwörter der Autor:innen

CX3CL1-CX3CR1 axisLuminal progenitor cells (luminal 2 cells)Prostate cancerTumor-associated macrophages (TAMs)

Substanzen

CX3C Chemokine Receptor 1Chemokine CX3CL1Cx3cr1 protein, mouse

Autor:innen und Institutionen

  • Biomedical Innovation Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, 100038, China.
  • Beijing Key Laboratory for Therapeutic Cancer Vaccines, Beijing, 100038, China.
  • National Clinical Research Center for Geriatric Diseases, Xuanwu Hospital of Capital Medical University, No. 45, Changchun Street, Xicheng District, Beijing, 100053, China.
  • Suzhou Xi'an Jiaotong-Liverpool Technology Transfer Center, Suzhou, 215009, China.
  • Laboratory Animal Resources Center, Tsinghua University, Beijing, 100084, China.
  • Institute of Immunology, School of Basic Medicine, Tsinghua University, Medical Science Building, Haidian District, Beijing, 100084, China. zhihualiu@tsinghua.edu.cn.

Förderung

  • the National Natural Science Foundation of China
  • Joint Research Center for Genomic Resources
  • State Key Laboratory of Membrane Biology

Zitieren

APA

Jiang, Y., Guo, Y., Han, L., Wang, S., Wang, F., Zhao, Y., Wang, J., Han, J., Liu, M., Liu, Z., & Zhang, Q. (2026). CX3CL1-CX3CR1 signaling orchestrates malignant progression of prostate cancer through luminal progenitor-macrophage crosstalk. Cellular Oncology. https://doi.org/10.1007/s13402-026-01179-5

Vancouver

Jiang Y, Guo Y, Han L, Wang S, Wang F, Zhao Y, et al. CX3CL1-CX3CR1 signaling orchestrates malignant progression of prostate cancer through luminal progenitor-macrophage crosstalk. Cellular Oncology. 2026. doi:10.1007/s13402-026-01179-5

BibTeX
@article{Jiang2026,
  author = {Jiang, Yu and Guo, Yuchen and Han, Lizhuang and Wang, Shiwei and Wang, Fang and Zhao, Yongliang and Wang, Jiajia and Han, Junyan and Liu, Miaomiao and Liu, Zhihua and Zhang, Qin},
  title = {CX3CL1-CX3CR1 signaling orchestrates malignant progression of prostate cancer through luminal progenitor-macrophage crosstalk},
  journal = {Cellular Oncology},
  year = {2026},
  doi = {10.1007/s13402-026-01179-5}
}
Kostenlos starten →